Navigation Links
PROCRIT(R) (Epoetin Alfa) Data to be Presented at American Society of Hematology Annual Meeting
Date:12/6/2007

alysis of real-world data from ESA-treated oncology

patients obtained from an ongoing prospective, observational registry,

Dosing and Outcomes Study of Erythropoiesis-Stimulating Therapies

(DOSE), to characterize hemoglobin levels or transfusion triggers.

Data were collected from participating hospital- and community-based

outpatient practices between December 2003 and July 2007.

About PROCRIT (Epoetin alfa)

PROCRIT is used for the treatment of anemia in patients with most types of cancer receiving chemotherapy, with chronic renal failure who are on dialysis and those who are not on dialysis, who are being treated with zidovudine for HIV infection, and to reduce the need for transfusion in anemic patients who are scheduled for elective noncardiac, nonvascular surgery. Depending on the country in which Epoetin alfa is marketed, these indications may differ.

Important U.S. Safety Information for PROCRIT

Boxed WARNINGS: INCREASED MORTALITY, SERIOUS CARDIOVASCULAR AND THROMBOEMBOLIC EVENTS, and TUMOR PROGRESSION

Renal failure: Patients experienced greater risks for death and serious cardiovascular events when administered erythropoiesis-stimulating agents (ESAs) to target higher versus lower hemoglobin levels (13.5 vs. 11.3 g/dL; 14 vs. 10 g/dL) in two clinical studies. Individualize dosing to achieve and maintain hemoglobin levels within the range of 10 to 12 g/dL.

Cancer:

-- ESAs shortened overall survival and/or time-to-tumor progression in

clinical studies in patients with advanced breast, head and neck,

lymphoid, and non-small cell lung malignancies when dosed to target a

hemoglobin of greater than or equal to 12 g/dL.

-- The risks of shortened survival and tumor progression have not been

excluded when ESAs are dosed to target a hemoglobin of < 12 g/dL.

-- To minimize these risks, as well as the risk of serious cardio- a
'/>"/>

SOURCE Ortho Biotech
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Results from Study Evaluating PROCRIT(R) in Intensive Care Unit Patients Published in New England Journal of Medicine
2. Ortho Biotech Reiterates Confidence in PROCRIT(R) (Epoetin alfa) Safety and Efficacy When Used According to Label
3. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
4. Pre-clinical Data on Recent Advances with HIV VLP Vaccine Presented at AIDS Vaccine 07 Conference
5. New Study Presented at WorldSleep 2007 Demonstrates Ramelteon Has Sustained Efficacy Over Six Months in Adults With Chronic Insomnia
6. Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology
7. Ozarelix Phase 2 Data Presented at 29th Congress of the Societe Internationale dUrologie
8. GeoVax Successful HIV/AIDS Vaccine Trial Data Presented at AIDS Vaccine 2007 Conference
9. Study Results for Aclidinium Bromide, a Novel Anticholinergic, Presented at European Respiratory Society Annual Congress
10. Promising Data from Paratek Pharmaceuticals MAR Inhibitor Program Presented in Late Breaker Session at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
11. New Phase III Data Presented for Once Monthly Dosing Regimen of Risedronate to Treat Postmenopausal Osteoporosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... Research and Markets ( ... the  "2015 Strategies in the UK Nucleic ... offering.      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) ,  ... NAT laboratory practice, as well as key ... with significant market impact during the next ...
(Date:5/27/2015)... May 27, 2015 ... the addition of the  "North America Mammography ... - 2019)"  report to their offering. ... ,Mammography is a detailed type of imaging ... inspect breasts. A mammography exam, called a ...
(Date:5/27/2015)... OpportunityAnalyzer: Cushing,s Syndrome - Opportunity Analysis ... estimates that the 2013 sales for the Cushing,s ... the 6MM covered in this report. Pharmaceutical and ... and financial resources in the CS field, have ... strategies. One notable example is the fact that ...
Breaking Medicine Technology:North America Mammography Market - Growth, Trends And Forecasts (2014 - 2019) 2OpportunityAnalyzer: Cushing's Syndrome - Opportunity Analysis and Forecasts to 2018 2OpportunityAnalyzer: Cushing's Syndrome - Opportunity Analysis and Forecasts to 2018 3OpportunityAnalyzer: Cushing's Syndrome - Opportunity Analysis and Forecasts to 2018 4
... Impressive Single Agent Efficacy in Patients who Progressed after ... after Treatment with both a VEGF Receptor Inhibitor and ... Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX ) today ... the Company,s Akt-inhibitor for cancer, as a treatment for ...
... Gene Expression in Female and Male Patients Presented at ASCO ... (Nasdaq: GHDX ) today announced results from a ... type DX(R) breast cancer test in a large number ... guide treatment with chemotherapy. The results, which will be presented ...
Cached Medicine Technology:Keryx Biopharmaceuticals Reports Single Agent Phase 2 Data of KRX-0401 (Perifosine) Further Demonstrating KRX-0401's Activity in the Treatment of Advanced Metastatic Renal Cell Cancer 2Keryx Biopharmaceuticals Reports Single Agent Phase 2 Data of KRX-0401 (Perifosine) Further Demonstrating KRX-0401's Activity in the Treatment of Advanced Metastatic Renal Cell Cancer 3Keryx Biopharmaceuticals Reports Single Agent Phase 2 Data of KRX-0401 (Perifosine) Further Demonstrating KRX-0401's Activity in the Treatment of Advanced Metastatic Renal Cell Cancer 4Keryx Biopharmaceuticals Reports Single Agent Phase 2 Data of KRX-0401 (Perifosine) Further Demonstrating KRX-0401's Activity in the Treatment of Advanced Metastatic Renal Cell Cancer 5Genomic Health Study Shows Breast Cancers in Men Display Very Similar Gene Signatures to Those in Women 2Genomic Health Study Shows Breast Cancers in Men Display Very Similar Gene Signatures to Those in Women 3Genomic Health Study Shows Breast Cancers in Men Display Very Similar Gene Signatures to Those in Women 4Genomic Health Study Shows Breast Cancers in Men Display Very Similar Gene Signatures to Those in Women 5
(Date:5/27/2015)... Ticket Down is a reputable source of 2015 NHL Western ... the middle of their series against the Anaheim Ducks with the ... Blackhawks can win tonight at home, this will tie up the ... the Honda Center in Anaheim. , During the regular season, ... as they won the Pacific Division by 8 points ahead of ...
(Date:5/27/2015)... The BBB Code of Business Practices represents sound advertising, ... and confidence in business. The Code is built on ... important elements of creating and maintaining trust in business. ... BBB. Businesses based in the United States and Canada ... be accredited by BBB. , To be accredited by ...
(Date:5/27/2015)... May 27, 2015 With the launch ... more robust Network Management Module (NMM) tool, monitoring provider-network ... 21 issue of Atlantic Information Services, Inc.’s (AIS) Medicare ... NMM tool, as well as analysis from industry experts ... The changes coming to the NMM were announced at ...
(Date:5/27/2015)... 2015 The new http://www.carsonenergy.com ... investors should consider oil and gas investing, the substantial ... are drilled, industry news, IRA investing, definitions and acronyms, ... of knowledge and experience is now in one central ... be able to access 24 hours a day, 7 ...
(Date:5/27/2015)... 27, 2015 The Case Management ... partnership to provide CMSA's Career and Knowledge Pathways ... seeks to strengthen the case/care management workforce by ... program. The mutually beneficial agreement provides Medix, a ... of talent in the healthcare, scientific and IT ...
Breaking Medicine News(10 mins):Health News:Blackhawks vs. Ducks NHL Western Conference Finals Tickets: Ticket Down Slashes Ticket Prices on Chicago Blackhawks vs. Anaheim Ducks 2015 NHL Western Conference Finals 2Health News:Carson Energy Receives A+ Accredited Rating For 19 Consecutive Years 2Health News:AIS Newsletter Offers Coverage, Analysis of New CMS Strategy on Monitoring MA Provider Access 2Health News:AIS Newsletter Offers Coverage, Analysis of New CMS Strategy on Monitoring MA Provider Access 3Health News:Carson Energy Launches Next Generation Investor Website 2Health News:Case Management Society of America Partners with Medix to Offer Career and Knowledge Pathways 2Health News:Case Management Society of America Partners with Medix to Offer Career and Knowledge Pathways 3
... site in a mouse brain well connected to other ... entire brainafter one injection of gene therapy. If these ... may have a potential method for gene therapy to ... neurological disorders, such as Tay-Sachs disease. , Researchers from ...
... to Health Coverage Expected to Increase for Small Business Owners ... http://www.bluecrossca.com/click4biz ... business sector,is one of the fastest growing segments of California,s ... provide their,employees with health insurance. Blue Cross of California has ...
... in antioxidant vitamins and minerals does not seem to prevent ... finds a study published on bmj.com today. , ... loss in older people. It is caused by the progressive ... in the centre of the retina at the back of ...
... MONICA, Calif., Oct. 8 Proposed,regulations that would ... stem cell research grants to for-profit organizations fail,to ... for California taxpayers,paying for the research, the Foundation ... "To ensure that the people who have paid ...
... fitness,and healthy living in communities across the USA, is ... held in conjunction with the 30th,anniversary of the Detroit ... Expo, which runs Oct. 19-20 at Cobo,Center, exemplifies that ... that provide services to runners. The Detroit Free ...
... Veterinary Medical Association awarded its 2007 Student/Recent,Graduate Award, ... in Lacey. (Logo: http://www.newscom.com/cgi-bin/prnh/20070613/WSVMALOGO ), ... of his dedication to,organized veterinary medicine in Washington. ... Veterinary Medicine, he has served as a,member of ...
Cached Medicine News:Health News:One shot of gene therapy spreads through brain in animal study 2Health News:One shot of gene therapy spreads through brain in animal study 3Health News:New Online Tool Makes Enrollment in Blue Cross of California Easier 2Health News:Antioxidants do not prevent degenerative eye disease 2Health News:Revised California Stem Cell Research Rules Fail to Ensure Affordable Access to Cures, Consumers Warn 2Health News:Saturn Shows Its Commitment to Health and Fitness by Becoming Expo Title Sponsor for The Detroit Free Press/Flagstar Marathon 2Health News:Lacey Veterinarian Awarded 2007 WSVMA Recent Graduate Award 2
... The Millennium 2000 is a unique microprocessor ... 4 microplates in either 96 or 384 ... programmed via the control panel and all ... remain visible under the clear protective cover. ...
Modular flow cytometer with all options....
This unique system combines the analytical power of a research cytometer into a compact, truly walk away, clinical analyzer ergonomically designed to expedite sample throughput....
... IMMULITE 2000, a continuous random access ... 200 tests per hour, has been ... consolidation in medium- and high-volume laboratories. ... its self-explanatory graphical user interface, offers ...
Medicine Products: